Seeking a fast-track approval for its COVID-19 vaccine, US major Pfizer has told Indian authorities that its jab has shown "high effectiveness" against the SARS-CoV-2 variant found in India and on people of Indian ethnicity or nationality, while it is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees, sources said on Wednesday.

Our vaccine highly effective on COVID-19 variant found in India, suitable for 12 yrs and above: Pfizer to Govt

A new British study has found that Pfizer COVID-19 vaccine is more effective if the second dose is delayed to 12-weeks after the first. The study, which has not yet been peer reviewed—found that delaying the second dose to 12 weeks led to an antibody response that was three-and-half times larger than when vaccine doses were kept to the standard recommendation of three weeks apart

Study: Pfizer COVID-19 vaccine doses more effective with a 12-week gap

Teenagers across the United States lined up to get their jabs against COVID-19 on Thursday, a day after CDC gave its green light to the use of Pfizer vaccine for children above 12 years of age.

Children over the age of 12 get vaccinated against COVID-19 across US

The US Food and Drugs Administration (FDA) on Monday gave its approval to the use of the Pfizer-BioNTech coronavirus vaccine for children in the age group of 12-15.

US approves Pfizer-BioNTech's Covid vaccine for children aged 12-15

Pfizer sharply increased its projections for 2021 revenues and profits on Tuesday, citing much higher COVID-19 vaccine sales as it targets the inoculations as a "durable" revenue stream.

Pfizer raises 2021 sales forecast for Covid vaccines to $26 billion

Pfizer is in discussions with the Indian government seeking an expedited approval pathway for its COVID-19 vaccine, the company’s Chief Executive Officer (CEO) Albert Bourla said on Monday.

Pfizer in talks with Indian govt over expedited approval of COVID-19 vaccine

Pfizer Inc's shipment of COVID-19 vaccine to Mexico this week includes doses made in its US plant, the first of what are expected to be ongoing exports of its shots from the United States.

Pfizer to export COVID-19 shots from its US plant, first doses sent to Mexico

Australia's medicines regulator will investigate two deaths for possible links to the COVID-19 vaccine, raising fresh concerns as the country seeks to accelerate an immunisation programme that has widely missed its initial vaccination targets.

Australia's medicines regulator to investigate two deaths for possible links to COVID-19 vaccine

The co-founder of BionNTech on Wednesday said that testing of the coronavirus variant first found in India is underway and expressed confidence its vaccine will work against the strain.

BioNTech founder 'confident' its Covid vaccine willl work against strain first found in India

Pfizer, the US pharma giant, is planning to make a new version of its Covid vaccine that can be stored in standard freezer and comes ready for use. Currently, the Pfizer vaccine needs to be stored at minus 70 degrees Celsius.

New version of Pfizer Covid vaccine won't need ultra-low temperature for storage

One shot of the Oxford/AstraZeneca or Pfizer/BioNTech vaccine reduces coronavirus infections by nearly two-thirds and protects older and more vulnerable people as much as younger, healthy individuals, a study has found.

One dose of Pfizer or Oxford jab reduces coronavirus infection rate by 65%, says study

US drugmaker Pfizer on Wednesday confirmed that suspect doses of its coronavirus vaccine that were seized in Mexico and Poland were indeed fake, with doses going for as much as $1,000 a shot, according to US media.

Pfizer identifies fake COVID-19 shots abroad as criminals exploit vaccine demand

The CEO of Pfizer Albert Bourla says that there is likely a need for a third dose of booster shot somewhere between 6 and 12 months and then form there will be annual revaccination but all of that needs to be confirmed. Health official says the emergence of the new variant is the primary reason.

Pfizer CEO Albert Bourla raises possibility of 'annual revaccination '

Hong Kong will resume administering the Pfizer/BioNTech coronavirus jab on Monday after the pharma giant said a packaging flaw that temporarily halted its use did not affect its safety, officials said.

Hong Kong to resume Pfizer/BioNTech vaccine roll-out on Monday

Hong Kong's government said an initial investigation by Germany's BioNTech and Fosun Industrial into its coronavirus vaccine did not show any "obvious systemic factors" during packaging after use of the vaccine was suspended in the city and neighbouring Macau this week.

Initial investigation of Pfizer vaccines shows no 'obvious systemic factors', Hong Kong says

Pfizer-BioNTech's coronavirus vaccine has an efficacy of 97 per cent in preventing symptomatic disease, a study based on real-world evidence published on Thursday said.

Pfizer vaccine 97% effective in preventing symptomatic Covid-19 disease: Study

The new guidelines issued by the US Centres for Disease Control(CDS) and prevention say that people who have been fully vaccinated can safely meet other vaccinated people without wearing masks.

People who have been vaccinated can meet other vaccinated people without masks: CDC

Australia has finally started its much-awaited vaccine rollout program. Top officials among a small group of people receiving the very first jab in the country. Prime Minister Scott Morrison was one of the first recipients of Pfizer.

Australia begins inoculation with Pfizer jab

Kenya received over a million doses of the AstraZeneca COVID-19 vaccine on Wednesday, while Rwanda said it was the first in Africa to secure shots from Pfizer, as efforts to inoculate the world's poorest nations accelerated.

Kenya calls first vaccines 'bazookas', Rwanda secures Pfizer shots

A single dose of Pfizer-BioNTech's coronavirus vaccine is enough to provide strong protection to those people who have had the deadly virus, two studies from the UK claim.

Pfizer vaccine's single dose provides strong immunity to those who have had Covid-19: Study

The Australian Parliament on Thursday approved the new law that will make it compulsory for Google and Facebook to pay media companies for news content published on their platforms.

Morning news brief: Facebook-Australia row, Pfizer's vaccine, and more

A massive study involving 1.2 million people published on Wednesday showed that Pfizer-BioNTech's coronavirus vaccine is 94 per cent effective. For the Israeli study, published in the New England Journal of Medicine, nearly 600,000 people received Pfizer's drug and an equal number of people did not receive the shots.

Large study shows Pfizer's coronavirus vaccine 94% effective

While countries like India are sending free vaccines to poorer nations, there are companies like Pfizer which are bullying governments. The US-based company Pfizer is holding governments to ransom, interfering with their legislation, and even demanding military bases as guarantee.

How Pfizer tried to bully Argentina and Brazil in exchange for vaccines

A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc-BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday.

South African variant could reduce vaccine protection: Pfizer

pfizer-vaccine

Pfizer Vaccine, News on Pfizer Vaccine, stories on Pfizer Vaccine, articles on Pfizer Vaccine, Pfizer Vaccine stories at Wion, Pfizer Vaccine news, Pfizer Vaccine latest news

pfizer vaccine